McPherson and National Disability Insurance Agency [2021] AATA 4682 (17 December 2021)
Division:NATIONAL DISABILITY INSURANCE SCHEME DIVISION
File Number(s): 2020/4290
Re:Stephen McPherson
APPLICANT
National Disability Insurance AgencyAnd
RESPONDENT
Decision
Tribunal:Member Dr C Huntly
Date:17 December 2021
Place:Perth
The reviewable decision, made on 3 July 2020, refusing the request by Mr McPherson for funding for a Defibrillator machine, is affirmed.
............[sgd]............................................................
Member Dr C Huntly
Catchwords
NATIONAL DISABILITY INSURANCE SCHEME – reasonable and necessary support – participant plan – whether support can be approved – defibrillator considered – decision under review affirmed.
Legislation
National Disability Insurance Scheme Act 2013 (Cth)
National Disability Insurance Scheme (Supports for Participants) Rules 2013 (Cth)
Cases
McGarrigle v National Disability Insurance Agency [2017] FCA 308
McLaughlin and National Disability Insurance Agency [2021] AATA 496
Buckley and National Disability Insurance Agency [2021] AATA 3622
Re Drake and Minister for Immigration and Ethnic Affairs (No 2) (1979) 2 ALD 634.
QDKH, by his litigation representative BGJF v National Disability Insurance Agency [2021] FCAFC 189
Secondary Materials
NDIS Operational Guideline – Including specific types of supports in plans
REASONS FOR DECISION
Member Dr C Huntly
17 December 2021
introduction
Mr McPherson (the Applicant) is a “participant” under the National Disability Insurance Scheme (the Scheme), on account of a squamous cell carcinoma of his tongue, and resultant resection surgeries of the tongue and throat walls. The Respondent (the Agency) administers the Scheme, pursuant to the National Disability Insurance Scheme Act 2013 (Cth) (the NDISAct).
On 29 April 2020, the Respondent approved a “Participant Plan” for the Applicant under s 33(2) of the Act,[1] which outlined the supports that were to be provided to him under the Scheme between 29 April 2020 and 29 April 2021 (Plan).
[1]T1D/8; T7/39.
On 4 May 2020, the Applicant requested an internal review of that decision,[2] to include payment for further supports. On 3 July 2020,[3] a delegate of the CEO of the Agency decided to affirm the decision not to include the supports he had requested. This is a decision susceptible to merits review by the Tribunal pursuant to s 103 of the NDIS Act.
[2]T5/37.
[3]T1F/20; T2.
On 16 July 2020, the Applicant applied to the Tribunal for merits review of the decision to refuse him this support.[4] The Tribunal is satisfied that the parties were given a reasonable opportunity to give evidence and present their arguments at the hearing, noting ss 33A and 39 of the Administrative Appeals Tribunal Act 1975 (Cth).
[4]T1/1.
facts
The Applicant was born in April 1960 and is currently 60 years of age.
The Applicant was diagnosed with a squamous cell carcinoma involving his tongue.
This has required numerous resections from 2018, the latest required a three-quarter glossectomy (surgical removal of the tongue), bilateral neck dissections with a free- flap reconstruction. Postoperative chemoradiation therapy was also required.[5][5]Exhibit A9 (Report of Dr Yuen dated 03 October 2020).
As a result of the…
Keep reading for free
Create a free CaseChat account to read McPherson and National Disability Insurance Agency and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2021] AATA 4682
- Decision Date
CaseChat Overview and Summary
The central legal issue before the AAT was whether a defibrillator constituted a "reasonable and necessary support" that could be funded under the NDIS. This required the Tribunal to interpret and apply specific provisions of the *National Disability Insurance Scheme Act 2013* (Cth), particularly sections 33(5), 34(1), and 35(1), which outline the criteria for approving participant supports and defining what constitutes reasonable and necessary supports.
The Tribunal reasoned that section 35(1)(b) of the NDIS Act permits the creation of rules prescribing supports that will not be funded. In this instance, a defibrillator was considered an excluded support under these rules. Consequently, the Tribunal found that no further consideration under section 34(1)(f) of the Act, which deals with whether a support is most appropriately funded through the NDIS, was necessary.
Accordingly, the AAT affirmed the NDIA's decision of 3 July 2020, which refused Mr McPherson's request for funding for a defibrillator machine.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Subsection 33(5) of the NDIS Act states that the matters to which the CEO must have regard in deciding whether or not to approve the statement of participant supports are as follows: …(5) In deciding whether or not to approve a statement of participant supports under subsection (2), the CEO must:(a)have regard to the participant’s statement of goals and aspirations; and(b)have regard to relevant assessments conducted in relation to the participant; and(c)be satisfied as mentioned in section 34 in relation to the reasonable and necessary supports that will be funded and the general supports that will be provided; and(d)apply [the Scheme] rules (if any) made for the purposes of section 35; and(e)have regard to the principle that a participant should manage his or her plan to the extent that he or she wishes to do so; and(f)have regard to the operation and effectiveness of any previous plans of the participant.(Emphasis added). With respect to ‘reasonable and necessary supports’ that will be funded, s 34(1) of the NDIS Act provides: (1) For the purposes of specifying, in a statement of participant supports, the general supports that will be provided, and the reasonable and necessary supports that will be funded, the CEO must be satisfied of all of the following in relation to the funding or provision of each such support:(a)the support will assist the participant to pursue the goals, objectives and aspirations included in the participant’s statement of goals and aspirations;(b)the support will assist the participant to undertake activities, so as to facilitate the participant’s social and economic participation;(c)the support represents value for money in that the costs of the support are reasonable, relative to both the benefits achieved and the cost of alternative support;(d)the support will be, or is likely to be, effective and beneficial for the participant, having regard to current good practice;(e)the funding or provision of the support takes account of what it is reasonable to expect families, carers, informal networks and the community to provide;(f) the support is most appropriately funded or provided through [the Scheme], and is not more appropriately funded or provided through other general systems of service delivery or support services offered by a person, agency or body, or systems of service delivery or support services offered:(i) as part of a universal service obligation; or(ii) in accordance with reasonable adjustments required under a law dealing with discrimination on the basis of disability.[Emphasis added]. Section 35 of the NDIS Act also provides as follows:(1) [The Scheme] rules may make provision in connection with the funding or provision of reasonable and necessary supports or general supports, including but not limited to prescribing:(a)methods or criteria to be applied, or matters to which the CEO is to have regard, in deciding, the reasonable and necessary supports or general supports that will be funded or provided under [the Scheme]; and(b)reasonable and necessary supports or general supports that will not be funded or provided under [the Scheme]; and(c)reasonable and necessary supports or general supports that will or will not be funded or provided under the [the Scheme] for prescribed participants. …(Emphasis added).